Stay updated with breaking news from Regulatory Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaceutical leaders and drugmakers criticized Texas Judge Kcasmaryk's decision to suspend the Food and Drug Administration's (FDA) approval of mifepristone.
Bridget Dooling reflects on Biden's regulatory actions one year into his presidency, and what it will take for his administration to have a lasting impact on regulatory policy.
On the whole, the Regulatory Accountability Act represents a positive step toward regulatory reform.
/PRNewswire/ -- The "Software as a Medical Device: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. The report provides an...
Biden is selecting top Democratic attorney Bob Bauer to serve as his personal lawyer as the Justice Department launches a classified documents probe.